OnKure Therapeutics develops small molecule drugs that target mutated forms of the PI3K alpha protein in cancer and other diseases. It last closed at $2.58 on Nov 17, down 6.18% on the day. In the past 30 days there were 1 dark pool print totaling $279K, the largest $279K.
OKUR · as of the Nov 17 close · updated after every close
Moving sideways
The stock is 5% below its 20 day and 5% below its 50 day average. It is 40% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 46). The nearest support is the Pivot S1 at $2.49, and the nearest resistance the Pivot at $2.59.
Short trendNeutral
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 10.7%/day
Key levels
$5.3852 week high+108.5%
$3.61200 day average+39.9%
$3.38100 day average+31.0%
$2.7220 day average+5.4%
$2.72Swing high (Oct 27)+5.4%
$2.7050 day average+4.7%
$2.69Pivot R1+4.3%
$2.59Pivot+0.4%
$2.58Last close
$2.49Pivot S1−3.5%
$2.31Swing low (Nov 6)−10.5%
$2.0152 week low−22.1%
Indicators
RSI (14)
45.67
Middle of its range
Neutral
MACD
0.05
Below its signal line
Bearish
Stochastic
26.7
Middle of its range
Neutral
ADX (14)
17.5
No clear trend
Williams %R
-79.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-33.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.2%
Change over 10 sessions
Bullish
ATR (14)
$0.28
Typical daily range, 10.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 22.1%/day
Key levels
$5.3852 week high+108.5%
$3.61200 day average+39.9%
$3.38100 day average+31.0%
$2.7220 day average+5.4%
$2.72Swing high (Oct 27)+5.4%
$2.7050 day average+4.7%
$2.69Pivot R1+4.3%
$2.59Pivot+0.4%
$2.58Last close
$2.49Pivot S1−3.5%
$2.31Swing low (Nov 6)−10.5%
$2.0152 week low−22.1%
Indicators
RSI (14)
39.11
Weak, oversold below 30
Neutral
MACD
-0.36
Below its signal line
Bearish
Stochastic
27.9
Middle of its range
Neutral
ADX (14)
17.9
No clear trend
Williams %R
-76.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-68.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−16.8%
Change over 10 sessions
Bearish
ATR (14)
$0.57
Typical daily range, 22.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for OKUR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OKUR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow OKUR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How OKUR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OKUR is in one of them and how their past OKUR trades turned out.
OnKure Therapeutics is a biopharmaceutical company based in Boulder, Colorado. It develops small molecule drugs that target specific mutated forms of the PI3K alpha protein, a driver of cancer and other diseases, while sparing the normal form of the protein. Its lead candidate, OKI-219, is in Phase 1 clinical trials for patients with advanced breast cancer, and the company is also researching treatments for vascular malformations.